Recent Finacing
Recent Raise
Esperion Therapeutics is a clinical-stage biopharmaceutical company in Plymouth, Michigan, developing ETC-1002, an oral once-daily small-molecule targeting lipid and carbohydrate metabolic pathways to lower LDL cholesterol.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors